Insulin-like growth factor I activates insulin receptor substrate 1 and Ras in human osteosarcoma cells

被引:3
作者
Lopaczynski, W [1 ]
Terry, C [1 ]
机构
[1] NCI, Endocrinol Sect, Metab Branch, Bethesda, MD 20892 USA
关键词
IGF-I receptor; tyrosine phosphorylation; IRS-1; Ras; c-Jun; MG-63;
D O I
10.18388/abp.1999_4189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factor I (IGF-I) stimulates multiplication of the human osteosarcoma cell line, MG-63, by acting through IGF-I receptor. We have characterized IGF-I stimulated phosphorylation of IRS-1, activation of Ras cycle and phosphorylation of c-Jun in this cell line. Serum starved MG-63 cells were (1) IGF-I stimulated and lysates were immunoprecipitated with polyclonal IRS-1 antibody or (2) metabolically labeled with [P-32]orthophosphoric acid and then cells were treated with IGF-I. Cell lysates were immunoprecipitated with p21Ras antibody (Y13-259) and bound nucleotides were analysed by thin-layer chromatography. We demonstrated tyrosine phosphorylation of IRS-1/2 immunoprecipitated from MG-63 cells stimulated with IGF-I. We also showed an increased level of GTP in p21Ras immunoprecipitates from IGF-I treated cells. Nuclear extracts prepared from P-32-labeled cells before and after addition of IGF-I were immunoprecipitated with c-Jun antibody. After electrophoresis and autoradiography, phosphorylation of the c-Jun band was seen to be IGF-I independent. Phosphoamino acid analysis of the c-Jun band showed that phosphoserine was the major species.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 27 条
[1]   Plasma insulin-like growth factor I and prostate cancer risk: A prospective study [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, E ;
Gann, PH ;
Ma, J ;
Wilkinson, P ;
Hennekens, CH ;
Pollak, M .
SCIENCE, 1998, 279 (5350) :563-566
[2]   Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I [J].
Cheng, HL ;
Feldman, EL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14560-14565
[3]   Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10 [J].
Dey, BR ;
Frick, K ;
Lopaczynski, W ;
Nissley, SP ;
Furlanetto, RW .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (06) :631-641
[4]   INSULIN-LIKE GROWTH-FACTOR-I INDUCES CYCLIN-D1 EXPRESSION IN MG63 HUMAN OSTEOSARCOMA CELLS IN-VITRO [J].
FURLANETTO, RW ;
HARWELL, SE ;
FRICK, KK .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (04) :510-517
[5]   RECEPTOR-MEDIATED ENDOCYTOSIS AND LYSOSOMAL PROCESSING OF INSULIN-LIKE GROWTH FACTOR-I BY MITOGENICALLY RESPONSIVE CELLS [J].
FURLANETTO, RW .
ENDOCRINOLOGY, 1988, 122 (05) :2044-2053
[6]   TRANSCRIPTION FACTOR ATF2 REGULATION BY THE JNK SIGNAL-TRANSDUCTION PATHWAY [J].
GUPTA, S ;
CAMPBELL, D ;
DERIJARD, B ;
DAVIS, RJ .
SCIENCE, 1995, 267 (5196) :389-393
[7]   Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [J].
Hankinson, SE ;
Willett, WC ;
Colditz, GA ;
Hunter, DJ ;
Michaud, DS ;
Deroo, B ;
Rosner, B ;
Speizer, FE ;
Pollak, M .
LANCET, 1998, 351 (9113) :1393-1396
[8]   TRANSFORMING GENE-PRODUCT OF ROUS-SARCOMA VIRUS PHOSPHORYLATES TYROSINE [J].
HUNTER, T ;
SEFTON, BM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (03) :1311-1315
[9]   Neural development: Are there any surprises left? [J].
Jessell, TM ;
Goodman, CS .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (01) :1-2
[10]   THE REGULATION OF AP-1 ACTIVITY BY MITOGEN-ACTIVATED PROTEIN-KINASES [J].
KARIN, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16483-16486